Skip to main content

Table 1 Patient Characteristics 1

From: Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

Characteristics No. of Patients %
Total enrolled 11  
Gender   
   Female 8 73
   Male 3 27
Age (y)   
   Median 55  
   Range 46-70  
ECOG performance status   
   1 6 55
   2 0 0
   3 3 27
   4 2 18
Histology   
   Adenocarcinoma 10 91
   Squamous 1 9
Smoking history   
   Current 3 27
   Ex-smoker 1 9
   Never 7 64
EGFR mutation   
   Exon 19 deletion 2 18
   L858R 1 9
   Not available 8 73
  1. EGFR, epidermal growth factor receptor.